통증 관리 디바이스 시장 : 업계 동향과 세계 예측(-2035년) - 디바이스 유형별, 신경 자극 디바이스 유형별, 용도별, 구입 형태별, 최종사용자별, 지역별

Pain Management Devices Market, Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Device, Type of Neurostimulation Device, Application Area, Mode of Purchase, End User and Geographical Regions

US $ 4,799 ￦ 6,630,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,670,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,644,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 24,869,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

통증 관리 디바이스 시장 규모는 2024년에 79억 4,000만 달러에 달할 것으로 보이며, 2035년까지의 예측 기간 중 CAGR 4.8%로 성장할 것으로 예측됩니다.

통증은 불쾌한 감각적 경험을 수반하는 복잡한 현상으로, 주로 급성 또는 만성적인 신체적 손상과 관련이 있으며 다양한 심리적, 생물학적, 사회적 요인에 의해 악화됩니다. 통증의 확산은 상당하며 전 세계에서 상당수의 개인에게 영향을 미치고 있습니다. 예를 들어 유럽에서는 프랑스와 독일을 합해 약 1억 5,000만 명의 인구가 만성 통증으로 고통받고 있으며, 이는 연간 3,000억 유로 이상의 경제적 부담을 초래하고 있습니다. 다양한 지역에서 통증이 광범위하게 퍼져있는 만큼, 환자의 예후를 개선하고 삶의 질을 향상시키기 위해서는 효과적인 통증 관리 솔루션이 필수적입니다.

통증 관리에는 일반적으로 근골격계 통증, 척수통, 신경병증성 통증 환자의 고통을 완화하기 위해 통증 관리 장비와 치료법이 사용됩니다. 오피오이드, 비스테로이드성 항염증약, 항우울제, 항경련제 등의 약리학적 개입은 급성 및 만성 통증을 관리하고 치료하기 위한 1차 선택 약물로 작용합니다. 오피오이드는 빠른 약효 발현과 즉각적인 통증 완화 효과로 인해 중등도에서 중증의 통증 관리에 가장 널리 사용되는 진통제 중 하나로 간주됩니다. 그러나 이러한 약물은 일상 활동을 방해하고, 심박수를 낮추며, 약물 중독과 사망으로 이어질 수 있는 행복감을 유발하는 등 심각한 부작용을 동반하며, 2019년 전 세계에서 약 600,000명의 사망자가 약물 과다 복용으로 인해 사망했으며, 이 중 약 80%가 오피오이드 과다 복용과 관련이 있다는 점에 유의하는 것이 중요합니다. 오피오이드 과다 복용과 관련이 있다는 것을 명심하는 것이 중요합니다.

오피오이드 사태로 인해 업계 이해관계자들은 신경 자극기, 주입 펌프, 고주파 절제 장비 등 환자 중심의 통증 관리 장비를 개발하여 통증을 효과적으로 관리할 수 있는 다양한 통증 관리 장비를 개발하게 되었습니다. 이러한 기기들은 통증 완화를 위한 2차 치료제로서 역할을 하고 있습니다. 이러한 장비들은 약물 상호작용이 거의 또는 전혀 없고, 표적 치료가 가능하며, 약물 의존도가 낮고, 부작용이 최소화되는 등 다양한 이점을 가지고 있습니다. 또한 이러한 기기는 개인의 필요에 따라 강도와 치료 시간을 조정할 수 있으며, 환자의 편안함을 향상시킬 수 있습니다. 이해관계자들이 환자 중심의 기기를 개발하기 위해 연구개발을 계속하고 있으므로 세계 통증 관리 기기 시장은 예측 기간 중 건전한 CAGR로 성장할 것으로 예상됩니다.

세계의 통증 관리 디바이스 시장에 대해 조사했으며, 시장의 개요와 디바이스 유형별, 신경 자극 디바이스 유형별, 용도별, 구입 형태별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 서문

제2장 조사 방법

제3장 경제 및 기타 프로젝트 특유의 고려 사항

제4장 개요

제5장 서론

• 챕터 개요
• 통증과 영향
• 통증의 분류
• 통증 관리의 역사적 진화
• 통증 관리 솔루션의 유형
• 향후 전망

제6장 시장 구도 : 주요 통증 관리 디바이스 개발 기업

• 챕터 개요
• 주요 통증 관리 디바이스 개발 기업 : 시장 구도

제7장 기업 경쟁력 분석

• 챕터 개요
• 전제와 주요 파라미터
• 조사 방법
• 주요 통증 관리 디바이스 개발 기업 : 기업 경쟁력 분석
• 주요 통증 관리 디바이스 개발 기업 : 벤치마킹 분석

제8장 기업 개요

• 챕터 개요
• Abbott
• Avanos Medical
• Becton, Dickinson and Company(BD)
• Medtronic
• Nalu Medical
• Nevro
• ZetrOZ Systems
• Zynex Medical
• Key Winning Strategies of Leading Players
• Other Leading Players
• Hexainnoheal
• 기타 기업의 주요 전략

제9장 출판물 분석

제10장 Porter's Five Forces 분석

제11장 시장 영향 분석

• 챕터 개요
• 시장 촉진요인
• 시장 억제요인
• 시장의 기회
• 시장이 해결해야 할 과제
• 결론

제12장 세계의 통증 관리 디바이스 시장

• 챕터 개요
• 전제와 조사 방법
• 2035년까지의 세계 통증 관리 디바이스 시장
• 주요 시장 세분화

제13장 통증 관리 디바이스 시장, 통증 관리 디바이스 유형별

제14장 통증 관리 디바이스 시장, 신경 자극 디바이스 유형별

제15장 통증 관리 디바이스 시장, 용도별

제16장 통증 관리 디바이스 시장, 구입 형태별

제17장 통증 관리 디바이스 시장, 최종사용자별

제18장 통증 관리 디바이스 시장, 지역별

제19장 통증 관리 디바이스 시장, 주요 업계 참여 기업별 분석

제20장 결론

제21장 부록 1 : 표 형식 데이터

제22장 부록 2 : 기업 및 조직 리스트

KSA

영문 목차

영문목차

The Pain Management Devices Market is valued at USD 7.94 billion in 2024 and is anticipated to grow at a CAGR of 4.8 %, during the forecast period, till 2035.

Pain is a complex phenomenon involving unpleasant sensory experience, primarily associated with acute or chronic physical injury exacerbated by various psychological, biological, and social factors. The prevalence of pain is substantial, affecting a significant number of individuals globally. For instance, in Europe, chronic pain affects approximately 150 million individuals, equivalent to the combined population of France and Germany, leading to an annual economic burden of more than EUR 300 billion. Given the widespread prevalence of pain across various geographies, effective pain management solutions are crucial to improve patient outcomes and enhance the quality of life.

Pain management typically involves the use of pain management devices and therapies to alleviate the suffering of individuals with musculoskeletal pain, spinal and neuropathic pain. Pharmacological interventions, such as opioids, nonsteroidal anti-inflammatory drugs, antidepressants, and antiepileptics, serve as a first-line treatment option for managing and treating both acute and chronic pain. Opioids are considered one of the most widely used pain medications for managing moderate to severe pain, owing to their rapid onset of medicinal effect and ability to provide immediate pain relief. However, these drugs are associated with significant side effects, such as inducing a euphoric state that may hamper daily activities, lower heart rate, and potentially lead to drug addiction and death. It is important to note that in 2019, approximately 600,000 deaths were attributed to drug overdose worldwide, with nearly 80% of these deaths related to the overuse of opioids.

The opioid crisis has prompted industry stakeholders to develop a vast array of patient-centric pain management devices, including neurostimulation devices, infusion pumps, and radiofrequency ablation devices, to manage pain effectively. These devices serve as a second-line treatment option for decreasing pain. These devices offer various advantages, such as minimal or no drug interaction, targeted therapy, reduced dependency on medications, and minimal adverse effects. Moreover, these devices can be tailored to individual needs, enabling adjustments in intensity and treatment duration, thereby improving patient comfort. Given the ongoing research and development efforts of stakeholders to develop patient-centric devices, the global pain management devices market is expected to grow at a healthy CAGR during the forecast period.

Key Market Segments

Type of Device

• Neurostimulation Devices
• Infusion Pump
• Ablation Devices
• Virtual Reality Devices
• Other Devices

Type of Neurostimulation Device

• Spinal Cord Stimulators
• Peripheral Nerve Stimulators
• Transcutaneous Electrical Nerve Stimulators
• Deep Brain Stimulators
• Other Stimulators

Application Area

• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Trauma and Surgical Pain
• Facial Pain and Migraine
• Other Application Areas

Mode of Purchase

• Prescription
• Over-the-Counter

End User

• Hospitals and Clinics
• Physiotherapy Centers
• Other End Users

Geographical Regions

• North America (US, Canada)
• Europe (France, Germany, Italy, Spain, UK, Rest of Europe)
• Asia-Pacific (Australia, China, India, Indonesia, Japan, South Korea, Rest of Asia-Pacific)
• Middle East and North Africa (Israel, Saudi Arabia, UAE)
• Latin America (Brazil, Mexico, Rest of Latin America)

Research Coverage:

• A brief introduction to pain and its impact, along with classification of pain and the historical development of the pain management domain over the years. It also provides details on various solutions for pain management, including therapeutics and medical devices. The chapter concludes with discussion on the key future perspectives within the pain management industry.
• An overview of the current market landscape of leading pain management device companies, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, type of device (neurostimulation devices, infusion pump, ablation devices, virtual reality devices and other devices), type of neurostimulation device (spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulators, deep brain stimulators and other stimulators), type of ablation device (radiofrequency ablation devices and cryoablation devices), type of analgesic infusion pump (external infusion pump and intrathecal pumps), type of treatment (invasive / minimally invasive and non-invasive), type of pain managed (acute pain and chronic pain), application area (musculoskeletal pain, post-operative pain, neuropathic pain, cancer pain, facial pain and migraine, trauma pain and other application areas).
• An insightful competitiveness analysis of the leading players engaged in the pain management devices market, based on several relevant parameters, such as company strength (in terms of years of experience and company size), portfolio strength (based on number of devices offered, type of pain management devices offered and type of pain managed) and application area. It also includes benchmarking analysis of the leading players based on various parameters, such as company strength, number of devices offered, type of pain management devices offered, type of pain managed and application area.
• Elaborate profiles of various prominent players that are currently involved in the pain management devices industry. Each company profile features a brief overview of the company, along with information on the location of headquarters, year of establishment, number of employees, business segments, leadership team, contact details, financial information (if available), product portfolio, recent developments and an informed future outlook.
• A detailed analysis of over 330 peer-reviewed, scientific articles related to pain management devices, based on several relevant parameters, such as year of publication, type of publication and popular keywords. The chapter also highlights the top journals, top publishers and top copyright holders.
• A qualitative Porter's five forces analysis, highlighting the five competitive forces prevalent in the pain management devices market, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute products and rivalry among existing competitors.
• An in-depth analysis of the factors that can impact the growth of the pain management devices industry. It also features the identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
• A detailed estimate of the current market size, opportunity and the future growth potential for pain management devices, over the next decade. Based on multiple parameters, likely adoption trends and through secondary research, we have provided an informed estimate on the market evolution during the forecast period, till 2035. The report also features the likely distribution of the current and forecasted opportunity. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.
• A detailed projection of the current size and future opportunity in the pain management devices market across different types of devices, such as neurostimulation devices, infusion pumps, ablation devices, virtual reality devices and other devices.
• A detailed projection of the current size and future opportunity in the pain management devices industry across different types of neurostimulation devices, such as spinal cord stimulators, peripheral nerve stimulators, transcutaneous electrical nerve stimulators, deep brain stimulators and other stimulators.
• A detailed projection of the current size and future opportunity for pain management device companies across different application areas, such as neuropathic pain, musculoskeletal pain, cancer pain, trauma and surgical pain, facial pain and migraine, and other application areas.
• A detailed projection of the current size and future opportunity in the pain management devices market across different modes of purchase, such as prescription mode and over-the-counter mode.
• A detailed projection of the current size and future opportunity in the pain management devices industry across different end users, such as hospitals and clinics, physiotherapy centers and other end users.
• A detailed projection of the current size and future opportunity in the pain management devices market across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America.

Key Benefits of Buying this Report

• The report provides valuable insights to market leaders and newcomers regarding the revenue estimations of the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the Pain Management Devices Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Companies Profiled

• Abbott
• AppliedVR
• AtriCure
• Avanos Medical
• Becton, Dickinson and Company
• BioElectronics
• Hexainnoheal
• Litemed
• Medtronic
• Micrel Medical Devices
• Nalu Medical
• Nevro
• Smileyscope
• Stryker
• ZetrOZ Systems
• Zynex Medical

TABLE OF CONTENTS

1. PREFACE

• 1.1. Introduction
• 1.2. Market Share Insights
• 1.3. Key Market Insights
• 1.4. Report Coverage
• 1.5. Key Questions Answered
• 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
• 2.3. Project Methodology
• 2.4. Forecast Methodology
• 2.5. Robust Quality Control
• 2.6. Key Market Segmentations
• 2.7. Key Considerations
  • 2.7.1. Demographics
  • 2.7.2. Economic Factors
  • 2.7.3. Government Regulations
  • 2.7.4. Supply Chain
  • 2.7.5. COVID Impact
  • 2.7.6. Market Access
  • 2.7.7. Healthcare Policies
  • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 3.1. Chapter Overview
• 3.2. Market Dynamics
  • 3.2.1. Time Period
    • 3.2.1.1. Historical Trends
    • 3.2.1.2. Current and Future Estimates
  • 3.2.2. Currency Coverage and Foreign Exchange Rate
    • 3.2.2.1. Major Currencies Affecting the Market
    • 3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
    • 3.2.2.3. Impact of Foreign Exchange Rate Volatility on The Market
    • 3.2.2.4. Strategies for Mitigating Foreign Exchange Risk
  • 3.2.3. Trade Policies
    • 3.2.3.1. Impact of Trade Barriers on the Market
    • 3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
  • 3.2.4. Recession
    • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 3.2.5. Inflation
    • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

• 5.1. Chapter Overview
• 5.2. Pain and Its Impact
• 5.3. Classification of Pain
  • 5.3.1. Acute Pain
  • 5.3.2. Chronic Pain
• 5.4. Historical Evolution of Pain Management
• 5.5. Types of Pain Management Solutions
  • 5.5.1. Pain Management Therapeutics
  • 5.5.2. Pain Management Devices
• 5.6. Future Perspectives

6. MARKET LANDSCAPE: LEADING PAIN MANAGEMENT DEVICE DEVELOPERS

• 6.1. Chapter Overview
• 6.2. Leading Pain Management Device Developers: Overall Market Landscape
  • 6.2.1. Analysis by Year of Establishment
  • 6.2.2. Analysis by Company Size
  • 6.2.3. Analysis by Location of Headquarters
  • 6.2.4. Analysis by Company Size and Location of Headquarters
  • 6.2.5. Analysis by Type of Pain Management Device
    • 6.2.5.1. Analysis by Type of Neurostimulation Device
    • 6.2.5.2. Analysis by Type of Ablation Device
    • 6.2.5.3. Analysis by Type of Analgesic Infusion Pump
  • 6.2.6. Analysis by Type of Treatment
  • 6.2.7. Analysis by Type of Pain Managed
  • 6.2.8. Analysis by Application Area
  • 6.2.9. Analysis by Type of Pain Management Device and Application Area

7. COMPANY COMPETITIVENESS ANALYSIS

• 7.1. Chapter Overview
• 7.2. Assumptions and Key Parameters
• 7.3. Methodology
• 7.4. Leading Pain Management Device Developers: Company Competitiveness Analysis
• 7.5. Leading Pain Management Device Developers: Benchmarking Analysis
  • 7.5.1. Benchmarking of Companies
    • 7.5.1.1. Abbott
    • 7.5.1.2. Medtronic
    • 7.5.1.3. Zynex Medical
    • 7.5.1.4. Boston Scientific
    • 7.5.1.5. OMRON Healthcare
  • 7.5.2. Benchmarking of Parameters
    • 7.5.2.1. Leading Pain Management Device Developers: Benchmarking by Competitiveness
    • 7.5.2.2. Leading Pain Management Device Developers: Benchmarking by Portfolio Strength
    • 7.5.2.3. Leading Pain Management Device Developers: Benchmarking by Application Area

8. COMPANY PROFILES

• 8.1. Chapter Overview
• 8.2. Abbott
  • 8.2.1. Company Overview
  • 8.2.2. Financial Information
  • 8.2.3. Product Portfolio
  • 8.2.4. Recent Developments and Future Outlook
• 8.3. Avanos Medical
  • 8.3.1. Company Overview
  • 8.3.2. Financial Information
  • 8.3.3. Product Portfolio
  • 8.3.4. Recent Developments and Future Outlook
• 8.4. Becton, Dickinson and Company (BD)
  • 8.4.1. Company Overview
  • 8.4.2. Financial Information
  • 8.4.3. Product Portfolio
  • 8.4.4. Recent Developments and Future Outlook
• 8.5. Medtronic
  • 8.5.1. Company Overview
  • 8.5.2. Financial Information
  • 8.5.3. Product Portfolio
  • 8.5.4. Recent Developments and Future Outlook
• 8.6. Nalu Medical
  • 8.6.1. Company Overview
  • 8.6.2. Financial Information
  • 8.6.3. Product Portfolio
  • 8.6.4. Recent Developments and Future Outlook
• 8.7. Nevro
  • 8.7.1. Company Overview
  • 8.7.2. Financial Information
  • 8.7.3. Product Portfolio
  • 8.7.4. Recent Developments and Future Outlook
• 8.8. ZetrOZ Systems
  • 8.8.1. Company Overview
  • 8.8.2. Product Portfolio
  • 8.8.3. Recent Developments and Future Outlook
• 8.9. Zynex Medical
  • 8.9.1. Company Overview
  • 8.9.2. Financial Information
  • 8.9.3. Product Portfolio
  • 8.9.4. Recent Developments and Future Outlook
• 8.10. Key Winning Strategies of Leading Players
• 8.11. Other Leading Players
  • 8.11.1. AppliedVR
  • 8.11.2. AtriCure
  • 8.11.3. BioElectronics

8.11.4.Hexainnoheal

• 8.11.5. Litemed
• 8.11.6. Micrel Medical Devices
• 8.11.7. Smileyscope
• 8.11.8. Stryker
• 8.12. Key Winning Strategies of Other Leading Players

9. PUBLICATION ANALYSIS

• 9.1. Chapter Overview
• 9.2. Scope and Methodology
• 9.3. Pain Management Devices: Publication Analysis
  • 9.3.1. Analysis by Year of Publication
  • 9.3.2. Analysis by Type of Publication
  • 9.3.3. Analysis by Copyright Holders
  • 9.3.4. Word Cloud: Emerging Focus Areas
  • 9.3.5. Most Active Publishers: Analysis by Number of Publications
  • 9.3.6. Key Journals: Analysis by Number of Publications
  • 9.3.7. Key Journals: Analysis by Impact Factor

10. PORTER'S FIVE FORCES ANALYSIS

• 10.1. Chapter Overview
• 10.2. Methodology and Assumptions
• 10.3. Key Parameters
  • 10.3.1. Threats of New Entrants
  • 10.3.2. Bargaining Power of End-Users
  • 10.3.3. Bargaining Power of Product Developers
  • 10.3.4. Threats of Substitute Products
  • 10.3.5. Rivalry Among Existing Competitors
• 10.4. Concluding Remarks

11. MARKET IMPACT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Market Drivers
• 11.3. Market Restraints
• 11.4. Market Opportunities
• 11.5. Market Challenges
• 11.6. Conclusion

12. GLOBAL PAIN MANAGEMENT DEVICES MARKET

• 12.1. Chapter Overview
• 12.2. Assumptions and Methodology
• 12.3. Global Pain Management Devices Market, till 2035
  • 12.3.1. Scenario Analysis
• 12.4. Key Market Segmentations

13. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF PAIN MANAGEMENT DEVICE

• 13.1. Chapter Overview
• 13.2. Assumptions and Methodology
• 13.3. Pain Management Devices Market: Distribution by Type of Pain Management Device, 2024 and 2035
  • 13.3.1. Pain Management Devices Market for Neurostimulation Devices, till 2035
  • 13.3.2. Pain Management Devices Market for Infusion Pumps, till 2035
  • 13.3.3. Pain Management Devices Market for Ablation Devices, till 2035
  • 13.3.4. Pain Management Devices Market for Virtual Reality Devices, till 2035
  • 13.3.5. Pain Management Devices Market for Other Pain Management Devices, till 2035
• 13.4. Data Triangulation and Validation

14. PAIN MANAGEMENT DEVICES MARKET, BY TYPE OF NEUROSTIMULATION DEVICE

• 14.1. Chapter Overview
• 14.2. Assumptions and Methodology
• 14.3. Pain Management Devices Market: Distribution by Type of Neurostimulation Device, 2024 and 2035
  • 14.3.1. Pain Management Devices Market for Spinal Cord Stimulators, till 2035
  • 14.3.2. Pain Management Devices Market for Peripheral Nerve Stimulators, till 2035
  • 14.3.3. Pain Management Devices Market for Transcutaneous Electrical Nerve Stimulators, till 2035
  • 14.3.4. Pain Management Devices Market for Deep Brain Stimulators, till 2035
  • 14.3.5. Pain Management Devices Market for Other Stimulators, till 2035
• 14.4. Data Triangulation and Validation

15. PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION AREA

• 15.1. Chapter Overview
• 15.2. Assumptions and Methodology
• 15.3. Pain Management Devices Market: Distribution by Application Area, 2024 and 2035
  • 15.3.1. Pain Management Devices Market for Neuropathic Pain, till 2035
  • 15.3.2. Pain Management Devices Market for Musculoskeletal Pain, till 2035
  • 15.3.3. Pain Management Devices Market for Cancer Pain, till 2035
  • 15.3.4. Pain Management Devices Market for Trauma and Surgical Pain, till 2035
  • 15.3.5. Pain Management Devices Market for Facial Pain and Migraine, till 2035
  • 15.3.6. Pain Management Devices Market for Other Application Areas, till 2035
• 15.4. Data Triangulation and Validation

16. PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE

• 16.1. Chapter Overview
• 16.2. Assumptions and Methodology
• 16.3. Pain Management Devices Market: Distribution by Mode of Purchase, 2024 and 2035
  • 16.3.1. Pain Management Devices Market for Prescription, till 2035
  • 16.3.2. Pain Management Devices Market for Over-the-Counter, till 2035
• 16.4. Data Triangulation and Validation

17. PAIN MANAGEMENT DEVICES MARKET, BY END USERS

• 17.1. Chapter Overview
• 17.2. Assumptions and Methodology
• 17.3. Pain Management Devices Market: Distribution by End Users, 2024 and 2035
  • 17.3.1. Pain Management Devices Market for Hospitals and Clinics, till 2035
  • 17.3.2. Pain Management Devices Market for Physiotherapy Centers, till 2035
  • 17.3.3. Pain Management Devices Market for Other End Users, till 2035
• 17.4. Data Triangulation and Validation

18. PAIN MANAGEMENT DEVICES MARKET, BY GEOGRAPHICAL REGIONS

• 18.1. Chapter Overview
• 18.2. Assumptions and Methodology
• 18.3. Pain Management Devices Market: Distribution by Geographical Regions, 2024 and 2035
  • 18.3.1. Pain Management Devices Market in North America, till 2035
    • 18.3.1.1. Pain Management Devices Market in the US, till 2035
    • 18.3.1.2. Pain Management Devices Market in Canada, till 2035
  • 18.3.2. Pain Management Devices Market in Europe, till 2035
    • 18.3.2.1. Pain Management Devices Market in Germany, till 2035
    • 18.3.2.2. Pain Management Devices Market in France, till 2035
    • 18.3.2.3. Pain Management Devices Market in the UK, till 2035
    • 18.3.2.4. Pain Management Devices Market in Spain, till 2035
    • 18.3.2.5. Pain Management Devices Market in Italy, till 2035
    • 18.3.2.6. Pain Management Devices Market in Rest of Europe, till 2035
  • 18.3.3. Pain Management Devices Market in Asia-Pacific, till 2035
    • 18.3.3.1. Pain Management Devices Market in China, till 2035
    • 18.3.3.2. Pain Management Devices Market in Japan, till 2035
    • 18.3.3.3. Pain Management Devices Market in Australia, till 2035
    • 18.3.3.4. Pain Management Devices Market in India, till 2035
    • 18.3.3.5. Pain Management Devices Market in South Korea, till 2035
    • 18.3.3.6. Pain Management Devices Market in Rest of Asia-Pacific, till 2035
  • 18.3.4. Pain Management Devices Market in Middle East and North Africa, till 2035
    • 18.3.4.1. Pain Management Devices Market in Israel, till 2035
    • 18.3.4.2. Pain Management Devices Market in Saudi Arabia, till 2035
    • 18.3.4.3. Pain Management Devices Market in UAE, till 2035
  • 18.3.5. Pain Management Devices Market in Latin America, till 2035
    • 18.3.5.1. Pain Management Devices Market in Brazil, till 2035
    • 18.3.5.2. Pain Management Devices Market in Mexico, till 2035
    • 18.3.5.3. Pain Management Devices Market in Rest of Latin America, till 2035
• 18.4. Geographical Regions: Market Movement Analysis
• 18.5. Geographical Regions: Penetration-Growth (P-G) Matrix
• 18.6. Data Triangulation and Validation

19. PAIN MANAGEMENT DEVICES MARKET, BY LEADING INDUSTRY PLAYERS

• 19.1. Chapter Overview
• 19.2. Leading Industry Players

20. CONCLUSION

21. APPENDIX 1: TABULATED DATA

22. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATION

관련자료